Reams of safety data must be amassed to satisfy the FDA. Scientists struggle to navigate all that red tape. Many don’t even try.
Now the California Institute for Regenerative Medicine has stepped in – with an $18 million grant financed by state taxpayers, courtesy of 2004’s Proposition 71, which created the state agency.
For 3 1/2 years, the agency focused on the basic groundwork needed to someday use human embryonic stem cells to replace body parts damaged by injury or disease. Such cures are still far in the future.
Now the institute has a more immediate goal: boosting therapies that are much further along in development and more often rely on less glamorous adult stem cells.
The current icon shows Polistra using a Personal Equation Machine.